Phantom Neuro Implants Neural Interface in Humans for the First Time
October 20, 2026
Phantom X is designed to translate intended arm and hand movements into commands for robotic prosthetic limbs
Phantom X is designed to translate intended arm and hand movements into commands for robotic prosthetic limbs
Medtronic (NYSE: MDT) has claimed a CE mark for its latest portfolio of pacemakers designed for conduction system pacing, which taps into the heart’s natural electrical pathways.
A three-letter sequence repeating along a stretch of DNA could offer new clues about why some people are more susceptible to Alzheimer’s disease than others. The sequence, CCG, sits in a region of DNA that controls the gene FAM193B.
University of East Anglia researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients.
Researchers at the University of Colorado Anschutz have discovered how herpes simplex virus type 1 (HSV-1), the virus that causes cold sores, can fundamentally change how the brain’s immune cells respond to infection, revealing a potentially important connection between viral infection, chronic inflammation and Alzheimer’s disease.
Loneliness is common in older adults, and the mental and physical health risks associated with the condition are difficult for medical professionals to recognize and treat.
A new study in the IEEE Journal of Biomedical and Health Informatics reveals how scientists at Klick Labs created visual maps of sound frequencies (spectrograms) to identify complex, new patterns associated with type 2 diabetes, using only smartphone recordings of randomly selected short English sentences and participant sex as study criteria.
An international research team led by IMDEA Materials Institute and Universidad Politécnica de Madrid (UPM) has developed a method for manufacturing personalized cardiovascular medical devices using three-dimensional printing of nitinol, a superelastic alloy.
Results from a Phase I clinical trial led by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) show a possible way to improve therapy options for patients with relapsed or treatment-resistant B-cell blood cancers. The findings are published in Blood Cancer Discovery.
A new artificial intelligence tool developed by Northwestern Medicine scientists and collaborating institutions can help determine whether genetic variants associated with a severe form of childhood epilepsy will cause disease, according to a study published in the Journal of Clinical Investigation.